MED6 Antikörper (Middle Region)
Kurzübersicht für MED6 Antikörper (Middle Region) (ABIN953376)
Target
Alle MED6 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 134-164, Middle Region
-
Spezifität
- This antibody recognizes Human MED6 (Center).
-
Aufreinigung
- Protein A column, followed by peptide affinity purification
-
Immunogen
- KLH conjugated synthetic peptide between 134-164 amino acids from the Central region of human MED6
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- MED6 (Mediator Complex Subunit 6 (MED6))
-
Andere Bezeichnung
- MED6
-
Hintergrund
- Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors.Synonyms: ARC33, Activator-recruited cofactor 33 kDa component, Mediator complex 6, Mediator of RNA polymerase II transcription subunit 6, Renal carcinoma antigen NY-REN-28
-
Molekulargewicht
- 28425 Da
-
Gen-ID
- 10001
-
NCBI Accession
- NP_005457
-
Pathways
- Stem Cell Maintenance, Regulation of Lipid Metabolism by PPARalpha
Target
-